SAB Biotherapeutics, Inc.
NASDAQ:SABS
3.42 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -42.194 | -17.145 | -17.145 | 20.118 | -8.986 |
| Depreciation & Amortization
| 3.745 | 1.654 | 1.654 | 0.548 | 0.323 |
| Deferred Income Tax
| 0 | 0 | 0 | -0.002 | 0 |
| Stock Based Compensation
| 2.424 | 2.674 | 2.315 | 1.295 | 0.371 |
| Change In Working Capital
| 2.326 | 13.455 | 13.455 | -11.954 | -0.923 |
| Accounts Receivables
| 5.557 | 12.559 | 12.559 | -17.751 | -2.563 |
| Inventory
| 0 | 0 | 0 | 0.485 | 0 |
| Accounts Payables
| -2.702 | -2.936 | -2.936 | 5.212 | 1.555 |
| Other Working Capital
| -0.529 | 3.832 | 3.832 | 0.1 | 0.084 |
| Other Non Cash Items
| 8.579 | 3.48 | 3.48 | -0 | 0 |
| Operating Cash Flow
| -25.119 | 3.759 | 3.759 | 10.005 | -9.214 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.197 | -10.944 | -10.944 | -12.732 | -0.609 |
| Acquisitions Net
| 0.044 | 0.076 | 0 | 0.009 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -0.076 | -10.944 | 0 | 0 |
| Investing Cash Flow
| -0.153 | -10.944 | -10.944 | -12.723 | -0.609 |
| Financing Activities: | |||||
| Debt Repayment
| -0.39 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 67.164 | 0.077 | 0.007 | 9.9 | 0 |
| Common Stock Repurchased
| 0 | -5.521 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 67.164 | 39.791 | 34.34 | 0.662 | 4.305 |
| Financing Cash Flow
| 66.773 | 34.12 | 34.12 | 8.982 | 3.682 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0.018 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 41.519 | 26.935 | 26.935 | 6.264 | -6.142 |
| Cash At End Of Period
| 56.566 | 39.545 | 39.545 | 12.61 | 6.346 |